Global Superdisintegrants Market Insights Forecasts to 2033

• The Global Superdisintegrants Market Size Was Estimated at USD 527.85 Million in 2023
• The Market Size is Expected to Grow at a CAGR of around 5.21% from 2023 to 2033
• The Worldwide Superdisintegrants Market Size is Expected to Reach USD 876.99 Million by 2033
• Asia Pacific is predicted to Grow at the fastest CAGR throughout the projection period

The Global Superdisintegrants Market Size is predicted to exceed USD 876.99 Million by 2033, Growing at a CAGR of 5.21% from 2023 to 2033. This market expansion is owing to the rising demand for oral disintegrating agents, the increasing prevalence of neurological diseases, the rising occurrence of dysphagia, technological advancements, and financial investments in research and development sectors.

Market Overview

The superdisintegrants market is defined as the community sector that involves the manufacturing and distribution of superdisintegrants that promotes the breakdown of formulation into fine particles and enhance the absorption of the drug. The active pharmaceutical ingredients alone are not possible to formulate the tablets due to the presence of the small quantity. Hence, the role comes here of pharmaceutical excipients. Superdisintegrants, pharmaceutical excipients, serve a vital role in the drug development process to maintain the stability of the formulation.

 Superdisintegrants are added in tablet and capsule formulations to achieve rapid disintegration. There are two types of superdisintegrants: synthetic and natural. It works by two mechanistic approaches, including swelling and capillary water absorption. Examples of superdisintegrants are crospovidone, croscarmellose, sodium starch glycolate, etc. The rising prevalence of chronic diseases contributes to increasing demand for medications for diagnostic purposes, leading to an increase in consumption of superdisintegrants, resulting in market growth.

Report Coverage

This research report categorizes the global superdisintegrants market based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the global superdisintegrants market. Recent market developments and competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the global superdisintegrants market.

Driving Factors:

The increase in chronic illnesses and the aging population are driving growth in the global market for superdisintegrants. The use of oral disintegrating tablets (ODTs) to treat dysphagia and related disorders is growing in acceptance, and superdisintegrants are utilized to make sedative, antidepressant, antipsychotic, and antimigraine medications. Growing healthcare costs, younger generations' sedentary lifestyles, the rise in pediatric patients, and the increasing prevalence of neurological illnesses are all contributing to the demand for ODTs and fast-dissolving dosage forms. Especially for susceptible individuals, superdisintegrants improve medicine and patient adherence by facilitating rapid disintegration.

The demand for natural and safe superdisintegrants is being driven by more restrictive laws governing the pharmaceutical industry and increased government scrutiny. This allows the companies an opportunity to develop novel products and encourage competition, which will ultimately result in a substantial rise in the global market.

Restraining Factors

Healthcare costs in developed countries are increasing, making it difficult for low-income individuals to afford necessary treatments, and the lack of awareness about effective drugs further restricts market growth.

Market Segmentation

The global superdisintegrants market share is classified into product type and formulation.

• The crospovidone segment dominated the market with 28.11% of the share in 2023 and is anticipated to grow at a significant CAGR throughout the forecast period.

Based on the product type, the global superdisintegrants market is categorized into croscarmellose sodium, modified starch, ion exchange resin, modified cellulose, and crospovidone. Among these, the crospovidone segment dominated the market with 28.11% of the share in 2023 and is anticipated to grow at a significant CAGR throughout the forecast period. The segment growth is owing to the wide consumption of natural superdisintegrants as it is non-toxic, enhance disintegration effect, and viscoelasticity properties, aid aggregation, protect API from degradation, improve the solubility of the poorly solubility of drugs, and are highly porous.

• The tablets and capsules segment accounted for the largest market share of 57.05% in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe.

Based on the formulation, the global superdisintegrants market is categorized into tablets and capsules and mouth-dissolving films. Among these, the tablets and capsules segment accounted for the largest market share of 57.05% in 2023 and is expected to grow at a significant CAGR throughout the projected timeframe. The segmental expansion is attributed to the longer shelf life, better bioavailability, controlled drug delivery, better disintegration rate, rapid dissolution rate, entering into systemic circulation quicker, patient compliance, enhanced biopharmaceutical properties, and faster onset of action.

Regional Segment Analysis of the Global Superdisintegrants Market

• North America (U.S., Canada, Mexico) 
• Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific (China, Japan, India, Rest of APAC)
• South America (Brazil and the Rest of South America) 
• The Middle East and Africa (UAE, South Africa, Rest of MEA)

North America is anticipated to hold the largest share of the global superdisintegrants market over the predicted timeframe.

North America is anticipated to hold the largest share of the global superdisintegrants market over the predicted timeframe. The market growth in this region is primarily due to the surge in demand for generic drugs due to chronic diseases and a growing geriatric population. Orally disintegrating tablets are crucial for treating neurological disorders in this region. Technological advancements, R&D expenditure, and government support for novel drug development procedures and oral dosage forms are also driving the growth of the superdisintegrants industry. The rise in cases of Alzheimer's disease and migraines in the U.S. highlights the importance of these tablets in treating neurological disorders.

Asia Pacific is anticipated to grow at the fastest CAGR throughout the projected timeframe. It is projected that the superdisintegrants market in the Asia Pacific will expand significantly over the next several years. A fast-growing manufacturing base and an increasing healthcare sector are the two main drivers of this growth. This is anticipated to increase demand for advanced pharmaceuticals, which would greatly boost the regional market for superdisintegrants. China holds a substantial share of the market in the superdisintegrants industry in 2023 owing to its cost-competitive manufacturing base, a production-friendly regulatory framework, and a developing domestic economy that has increased disposable income and driven a sizable demand for pharmaceuticals.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the global superdisintegrants market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• JRS PHARMA
• Merck KGaA
• Ashland
• NIPPO SODA CO. LTD.
• Corel PharmaChem
• DuPont de Nemours, In
• Sigachi Industries Limited
• FMC Corporation
• BASF SE
• Boal NKY Pharmaceuticals Ltd.
• Rochem International Inc.
• Gangwal Healthcare
• Evonik
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Recent Developments

• In July 2024, JRS Pharma, a leading manufacturer of excipients, signed an agreement with Gujrat Microwax to establish a manufacturing facility for cotton-based croscarmellose sodium in Mehsana. This collaboration aims to boost the Indian excipient market and reduce the dependency on imports, with a focus on high-quality production standards.

• In July 2024, the FDA approved Femlyv (norethindrone acetate and ethinyl estradiol), the first orally disintegrating tablet approved for the prevention of pregnancy. This combination tablet is formulated for individuals dealing with swallowing difficulties. Femlyv should be dissolved on the tongue and followed with 240 ml of water. It should also be taken at the same time each day regardless of mealtimes.

Market Segment

This study forecasts revenue at global, regional, and country levels from 2023 to 2033. Spherical Insights has segmented the global superdisintegrants market based on the below-mentioned segments:

Global Superdisintegrants Market, By Product Type

• Croscarmellose Sodium
• Modified Starch
• Ion Exchange Resin
• Modified Cellulose
• Crospovidone

Global Superdisintegrants Market, By Formulation

• Tablets and Capsules
• Mouth Dissolving Films

Global Superdisintegrants Market, By Regional

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• Middle East & Africa
  • UAE
  • Saudi Arabia
  • Qatar
  • South Africa
  • Rest of the Middle East & Africa